Related Experiment Video
Updated: Jun 10, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
[Cardiovascular risk in HIV infected patients]
Pedro Raimundo1, A Miranda, J Ribeiro
1Serviço de Medicina Interna - Unidade Funcional 1.2, Hospital São José (CHLC), Lisboa.
Insights
HIV infection and its treatment increase cardiovascular risk. Endothelial dysfunction and metabolic issues contribute to early atherosclerosis, necessitating tailored prevention and optimized therapies.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- HIV infection is associated with increased cardiovascular risk.
- Antiretroviral therapy (ART) may also contribute to cardiovascular complications.
- Endothelial dysfunction and metabolic abnormalities are key mechanisms involved.
Purpose of the Study:
- To highlight the elevated cardiovascular risk in patients with HIV.
- To discuss the underlying mechanisms linking HIV and ART to cardiovascular disease.
- To emphasize the need for improved prevention and treatment strategies.
Main Methods:
- Review of existing literature on HIV, ART, and cardiovascular risk.
- Analysis of the pathophysiological links between HIV infection, ART, and atherosclerosis.
- Discussion of current and potential therapeutic interventions.
Main Results:
- Both HIV infection and ART are implicated in heightened cardiovascular risk.
- Endothelial dysfunction and metabolic disturbances predispose to premature atherosclerosis.
- Early identification of risk is crucial for effective management.
Conclusions:
- Patients with HIV are at increased risk for cardiovascular events.
- Management strategies should focus on preventing atherosclerosis.
- Optimizing ART and utilizing lipid-lowering agents are key therapeutic approaches.
Abstract:
The increased cardiovascular risk has been implicated in both HIV infection and antirretroviral therapy. The endothelial dysfunction triggered by the infection and the metabolic abnormalities associated with therapy predispose to premature atherosclerosis. The recognition of the increased cardiovascular risk in these patients will allow more appropriate prevention strategies, as well as therapy optimization with lipid-lowering agents and antirretroviral therapy modification.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Coronary Artery Disease IV: Preventive Measures
Cryptococcal Meningitis
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
